|
Roche May Face Fine in EU Over Alleged Pharmacovigilance Shortfalls
The European Medicines Agency (EMA) has initiated its first-ever infringement procedure against a drugmaker, alleging Roche did not report potential adverse events for 19 of its U.S. drugs.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives